Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

E Quoix, R Ramlau, V Westeel, Z Papai… - The lancet …, 2011 - thelancet.com
Background Chemotherapy is the standard of care for advanced stages of non-small-cell
lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified …
被引用次数：326 相关文章

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

E Quoix, R Ramlau, V Westeel, Z Papai… - The Lancet …, 2011 - infona.pl
Chemotherapy is the standard of care for advanced stages of non-small-cell lung cancer
(NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified vaccinia …

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

E Quoix, R Ramlau, V Westeel, Z Papai… - The Lancet …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Chemotherapy is the standard of care for advanced stages of non-small-cell
lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified …

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.

E Quoix, R Ramlau, V Westeel, Z Papai… - Lancet …, 2011 - inria.hal.science
BACKGROUND: Chemotherapy is the standard of care for advanced stages of non-small-
cell lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus …
[PDF] academia.edu

[PDF][PDF] Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

E Quoix, R Ramlau, V Westeel, Z Papai, A Madroszyk… - Lancet Oncol, 2011 - academia.edu
Background Chemotherapy is the standard of care for advanced stages of non-small-cell
lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified …

[引用][C] Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

E Quoix, R Ramlau, V Westeel, Z Papai… - The Lancet …, 2011 - cir.nii.ac.jp
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell
lung cancer: a controlled phase 2B trial | CiNii Research CiNii 国立情報学研究所 学術情報 …

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.

E Quoix, R Ramlau, V Westeel, Z Papai… - The Lancet …, 2011 - europepmc.org
Background Chemotherapy is the standard of care for advanced stages of non-small-cell
lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified …

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

E Quoix, R Ramlau, V Westeel, Z Papai… - The Lancet …, 2011 - Elsevier
BACKGROUND: Chemotherapy is the standard of care for advanced stages of non-small-
cell lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus …

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

E Quoix, R Ramlau, V Westeel, Z Papai… - The Lancet …, 2011 - thelancet.com
Background Chemotherapy is the standard of care for advanced stages of non-small-cell
lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified …

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.

E Quoix, R Ramlau, V Westeel, Z Papai… - Lancet …, 2011 - hal.science
BACKGROUND: Chemotherapy is the standard of care for advanced stages of non-small-
cell lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus …